Mbabane (AFP) – Eswatini begins administering a groundbreaking HIV-prevention injection in the drug’s first public rollouts in Africa, which has the world’s highest HIV burden. Lenacapavir, which is taken twice a year, has been shown to reduce the risk of HIV transmission by more than 99.9 percent, making it functionally akin to a powerful vaccine. Eswatini — a tiny kingdom of 1.2 million — has about 220,000 people living with the virus.
